Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Anthony Palmieri, PharmD, MBA
Articles
The Impact of Abuse Deterrent Technologies on Prescription Opioid Trends
Howard Oremland, RPh, MBA;Lauren G. Gallagher, MPH;John Schlie, PharmD;Dick Creager, MD, MPA;Anthony Palmieri, PharmD, MBA;Olga S. Matlin, PhD;Steven M. Kymes, PhD
October 11th 2013The authors examined trends in the utilization of prescription opioid medication following introduction of abuse deterrent technology for Oxycontin.
Read More
The Expanding Role of New Medications in the Treatment of Type 2 Diabetes Mellitus
Kristen Harrison, MPH;Frederick Brown, PharmD;Brandeis Seymore, RPh;Anthony Palmieri, PharmD, MBA;Olga S. Matlin, PhD;Steven M. Kymes, PhD
August 21st 2013We examined the prevalence of use and cost impact of DPP-4 inhibitors and GLP-1 receptor agonists in people with diabetes.
Read More
Latest Updated Articles
Published: June 12th 2025 | Updated: June 16th 2025
Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers
Published: June 10th 2025 | Updated: June 12th 2025
Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting Members
Published: June 2nd 2025 | Updated: June 11th 2025
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Published: June 3rd 2025 | Updated: June 11th 2025
ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape
Published: May 30th 2025 | Updated: June 5th 2025
Emerging Data: Impacts of ROCKstar and AGAVE-201
Published: April 18th 2025 | Updated: April 21st 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders
